The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 11th 2025
Explore recent FDA-approved drugs from August 2025.
FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD
September 19th 2017Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read More
FDA Approves Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women
September 18th 2017The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g.
Read More
The Cost, Quality, and Experience Impact of Population Health in Primary Care
Read More
FDA OKs Prescription-only App to Help Patients with Substance Use Disorders
September 15th 2017Data showed a statistically significant increase in adherence to abstinence for the patients with alcohol, cocaine, marijuana and stimulant SUD in those who used Reset, 40.3%, compared to the patients who did not, 17.6%.
Read More